Adam Scott Levy
CIK 1693134 · CFO and Secretary · last filed 2026-02-20
Adam Scott Levy is a CFO and Secretary who has filed 25 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for MLYS, was dated Feb 20, 2026. Across all open-market trades the lifetime net is −$9.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.15M
3
25
-$9.01M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MLYS | CFO and Secretary | 48,538 | $23.62 | $1.15M | -$9.06M | 16 | 2026-02-20 |
| Fresh Tracks Therapeutics, Inc. (BBI) Delisted | Chief Business Officer | — | $2.35 | — | $0 | 1 | 2020-03-18 |
| Viridian Therapeutics, Inc.\DE (MGEN) Delisted | Chief Business Officer | 13,040 | — | — | $51.5K | 8 | 2019-02-08 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-20 | MLYS | Grant (A) | +39,900 | $0 | EDGAR |
| 2026-01-13 | MLYS | Sell (S) | −10,758 | -$345.7K | EDGAR |
| 2025-11-13 | MLYS | Mixed | −13,871 | -$3.87M | EDGAR |
| 2025-10-15 | MLYS | Sell (S) | −10,758 | -$452.0K | EDGAR |
| 2025-07-30 | MLYS | Sell (S) | −73,678 | -$1.08M | EDGAR |
| 2025-07-15 | MLYS | Sell (S) | −10,758 | -$155.5K | EDGAR |
| 2025-04-15 | MLYS | Sell (S) | −10,757 | -$129.7K | EDGAR |
| 2025-02-24 | MLYS | Grant (A) | — | $0 | EDGAR |
| 2025-01-15 | MLYS | Sell (S) | −10,757 | -$97.9K | EDGAR |
| 2024-10-15 | MLYS | Sell (S) | −10,757 | -$146.0K | EDGAR |